Norton L - Search Results

1

Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy.

Hudis C, Seidman A, Baselga J, Raptis G, Lebwohl D, Gilewski T, Moynahan M, Sklarin N, Fennelly D, Crown JP, Surbone A, Uhlenhopp M, Riedel E, Yao TJ, Norton L. Hudis C, et al. Among authors: norton l. J Clin Oncol. 1999 Jan;17(1):93-100. doi: 10.1200/JCO.1999.17.1.93. J Clin Oncol. 1999. PMID: 10458222 Clinical Trial.

2

Adjuvant systemic therapy for early breast cancer.

Crown J, Norton L. Crown J, et al. Among authors: norton l. Semin Surg Oncol. 1991 Sep-Oct;7(5):283-90. doi: 10.1002/ssu.2980070510. Semin Surg Oncol. 1991. PMID: 1775813 Review.

3

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.

Seidman AD, Hudis CA, Fennelly D, Raptis G, Baselga J, Norton L. Seidman AD, et al. Among authors: norton l. Semin Oncol. 1995 Oct;22(5 Suppl 12):108-16. Semin Oncol. 1995. PMID: 7481852 Review.

4

Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Hakes TB, Lebwohl DE, Gilewski TA, Hudis CA, Surbone A, et al. Seidman AD, et al. Among authors: norton l. Oncology. 1994 Oct;51 Suppl 1:33-9. doi: 10.1159/000227414. Oncology. 1994. PMID: 7526308 Clinical Trial.

5

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy.

Seidman AD, Hudis CA, Norton L. Seidman AD, et al. Among authors: norton l. Semin Oncol. 1995 Aug;22(4 Suppl 8):3-8. Semin Oncol. 1995. PMID: 7543701 Clinical Trial.

6

Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, et al. Seidman AD, et al. Among authors: norton l. Semin Oncol. 1993 Aug;20(4 Suppl 3):40-5. Semin Oncol. 1993. PMID: 7688145 Clinical Trial.

7

[Kinetics of breast neoplasms].

Surbone A, Norton L. Surbone A, et al. Among authors: norton l. Minerva Med. 1994 Jan-Feb;85(1-2):7-16. Minerva Med. 1994. PMID: 8152580 Review. Italian.

8

Kinetic concepts in the treatment of breast cancer.

Surbone A, Norton L. Surbone A, et al. Among authors: norton l. Ann N Y Acad Sci. 1993 Nov 30;698:48-62. doi: 10.1111/j.1749-6632.1993.tb17190.x. Ann N Y Acad Sci. 1993. PMID: 8279784 Review. No abstract available.

9

Systemic adjuvant therapy for breast cancer.

Hudis CA, Norton L. Hudis CA, et al. Among authors: norton l. Curr Opin Oncol. 1993 Nov;5(6):982-90. doi: 10.1097/00001622-199311000-00006. Curr Opin Oncol. 1993. PMID: 8305548 Review.

10

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.

Hudis CA, Seidman AD, Crown JP, Balmaceda C, Freilich R, Gilewski TA, Hakes TB, Currie V, Lebwohl DE, Baselga J, Raptis G, Gollub M, Robles M, Bruno R, Norton L. Hudis CA, et al. Among authors: norton l. J Clin Oncol. 1996 Jan;14(1):58-65. doi: 10.1200/JCO.1996.14.1.58. J Clin Oncol. 1996. PMID: 8558221 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,018 results

Search Page

Filters